Moderna CEO Stéphane Bancel on second Covid vaccine booster shots

Moderna CEO Stephane Bancel told CNBC on Thursday that the drugmaker wanted to offer U.S. regulators “flexibility” in determining eligibility for a fourth dose of the Covid vaccine.

Moderna submitted its request last week for a so-called second recall, asking the Food and Drug Administration to allow the additional shot for all Americans 18 and older.

The biotech company’s request was considerably broader than that of competing mRNA vaccine maker Pfizer, whose request for the fourth dose only covered people aged 65 and over.

“I think we wanted to give regulators, the FDA and regulators in other countries, the flexibility,” Bancel said during an interview on “Squawk Box.” “You have people who are young adults who have comorbid factors, and they might need [a] sooner the fourth dose to protect them.”

Underlying medical conditions such as asthma, chronic lung disease and diabetes can put people at greater risk of becoming seriously ill from Covid.

Immunocompromised people are already eligible for four doses of the Covid vaccine. Their recommended regimen consists of three primary doses, with a booster given at least three months later.

Some doctors have questioned the need for four Covid injections for the general public in the short term. Additionally, less than half of fully vaccinated people have received their initial booster shot, according to data from the Centers for Disease Control and Prevention, and some experts suggest the focus should be on increasing that percentage. absorption.

“We have submitted all the data we need to provide [the FDA] the best possible information to make the best possible decision,” said Bancel.

cnbc Business

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.


Friendly bacon buff. Unapologetic problem solver. Avid food lover. Amateur alcoholaholic. Organizer. Student
Back to top button